Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Sleep Medicine Clinics

Volumn 2, Issue 2, 2007, Pages 237-250

  Aurora, R Nisha ^a   Punjabi, Naresh M ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADIPOCYTE; ADRENERGIC SYSTEM; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOXEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME;

EID: 35448985925     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2007.03.006     Document Type: Review

References (213)

1. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 14 (2002) 1723-1727
2. World Health Organization. Obesity and overweight. World Health Organization (2006). Available at: www.who.int/mediacentre/factsheets/fs311/en/index.html
3. Flegal K.M. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav 86 5 (2005) 599-602
4. Costa D.L., and Steckel R.H. Long-term trends in health, welfare, and economic growth in the United States. In: Steckel R.H., and Floud R. (Eds). Health and welfare during industrialization (1997), University of Chicago Press, Chicago 47-90
5. Pi-Sunyer F.X. NHLBI obesity education initiative expert panel on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 6 (1998) 51S-209S
6. Field A.E., Coakley E.H., Must A., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161 13 (2001) 1581-1586
7. Visscher T.L., and Seidell J.C. The public health impact of obesity. Annu Rev Public Health 22 (2001) 355-375
8. Finkelstein E.A., Fiebelkorn I.C., and Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying?. Health Aff (Millwood) (2003) Suppl Web Exclusives: W3-215-26
9. Center for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults-United States, 1999-2000. MMWR Morb Mortal Wkly Rep 52 35 (2003) 833-837
10. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 9 (1998) 1414-1431
11. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 5 (2004) 1047-1053
12. Golay A., and Ybarra J. Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab 19 4 (2005) 649-663
13. DeFronzo R.A. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88 4 (2004) 787-835 ix
14. Leahy J.L. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 36 3 (2005) 197-209
15. Punjabi N.M., and Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99 5 (2005) 1998-2007
16. Spiegel K., Knutson K., Leproult R., et al. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99 5 (2005) 2008-2019
17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 30 Suppl 1 (2007) S42-S47
18. Ducimetiere P., Eschwege E., Papoz L., et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19 3 (1980) 205-210
19. Pyorala K., Savolainen E., Kaukola S., et al. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl 701 (1985) 38-52
20. Despres J.P., Lamarche B., Mauriege P., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334 15 (1996) 952-957
21. Hanley A.J., Williams K., Stern M.P., et al. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25 7 (2002) 1177-1184
22. Punjabi N.M., Ahmed M.M., Polotsky V.Y., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 136 2-3 (2003) 167-178
23. Jennum P., Schultz-Larsen K., and Christensen N. Snoring, sympathetic activity and cardiovascular risk factors in a 70-year-old population. Eur J Epidemiol 9 5 (1993) 477-482
24. Grunstein R.R., Stenlof K., Hedner J., et al. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord 19 6 (1995) 410-418
25. Enright P.L., Newman A.B., Wahl P.W., et al. Prevalence and correlates of snoring and observed apneas in 5,201 older adults. Sleep 19 7 (1996) 531-538
26. Elmasry A., Janson C., Lindberg E., et al. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 248 1 (2000) 13-20
27. Al Delaimy W.K., Manson J.E., Willett W.C., et al. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 155 5 (2002) 387-393
28. Renko A.K., Hiltunen L., Laakso M., et al. The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract 67 1 (2005) 84-91
29. Joo S., Lee S., Choi H.A., et al. Habitual snoring is associated with elevated hemoglobin A1c levels in non-obese middle-aged adults. J Sleep Res 15 4 (2006) 437-444
30. Lindberg E., Berne C., Franklin K.A., et al. Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women-a population-based study. Respir Med (2006) in press
31. Levinson P.D., McGarvey S.T., Carlisle C.C., et al. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 103 5 (1993) 1336-1342
32. Tiihonen M., Partinen M., and Narvanen S. The severity of obstructive sleep apnoea is associated with insulin resistance. J Sleep Res 2 1 (1993) 56-61
33. Strohl K.P., Novak R.D., Singer W., et al. Insulin levels, blood pressure and sleep apnea. Sleep 17 7 (1994) 614-618
34. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 3 (2000) 1151-1158
35. Ip M.S., Lam K.S., Ho C., et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118 3 (2000) 580-586
36. Elmasry A., Lindberg E., Berne C., et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 249 2 (2001) 153-161
37. Ip M.S., Lam B., Ng M.M., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 5 (2002) 670-676
38. Punjabi N.M., Sorkin J.D., Katzel L.I., et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165 5 (2002) 677-682
39. Manzella D., Parillo M., Razzino T., et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord 26 3 (2002) 370-375
40. De La Eva R.C., Baur L.A., Donaghue K.C., et al. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 140 6 (2002) 654-659
41. Meslier N., Gagnadoux F., Giraud P., et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 22 1 (2003) 156-160
42. Punjabi N.M., Shahar E., Redline S., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160 6 (2004) 521-530
43. Makino S., Handa H., Suzukawa K., et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 64 1 (2006) 12-19
44. Evans D.J., Hoffmann R.G., Kalkhoff R.K., et al. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 33 1 (1984) 68-75
45. Cefalu W.T., Wang Z.Q., Werbel S., et al. Contribution of visceral fat mass to the insulin resistance of aging. Metabolism 44 7 (1995) 954-959
46. Banerji M.A., Faridi N., Atluri R., et al. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84 1 (1999) 137-144
47. Kobayashi H., Nakamura T., Miyaoka K., et al. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Jpn Circ J 65 3 (2001) 193-199
48. Sironi A.M., Gastaldelli A., Mari A., et al. Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension 44 2 (2004) 127-133
49. Kim C.S., Nam J.Y., Park J.S., et al. The correlation between insulin resistance and the visceral fat to skeletal muscle ratio in middle-aged women. Yonsei Med J 45 3 (2004) 469-478
50. Ohlson L.O., Larsson B., Svardsudd K., et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34 10 (1985) 1055-1058
51. Kaditis A.G., Alexopoulos E.I., Damani E., et al. Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol 40 6 (2005) 515-523
52. Tauman R., O'Brien L.M., Ivanenko A., et al. Obesity rather than severity of sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children. Pediatrics 116 1 (2005) e66-e73
53. Saini J., Krieger J., Brandenberger G., et al. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 25 7 (1993) 375-381
54. Stoohs R.A., Facchini F.S., Philip P., et al. Selected cardiovascular risk factors in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure (n-CPAP). Sleep 16 8 Suppl (1993) S141-S142
55. Brooks B., Cistulli P.A., Borkman M., et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 79 6 (1994) 1681-1685
56. Davies R.J., Turner R., Crosby J., et al. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring: their comparison with matched controls and response to treatment. J Sleep Res 3 3 (1994) 180-185
57. Cooper B.G., White J.E., Ashworth L.A., et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18 3 (1995) 172-179
58. Saarelainen S., Lahtela J., and Kallonen E. Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 6 2 (1997) 146-147
59. Chin K., Shimizu K., Nakamura T., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100 7 (1999) 706-712
60. Smurra M., Philip P., Taillard J., et al. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med 2 3 (2001) 207-213
61. Harsch I.A., Schahin S.P., Bruckner K., et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 71 3 (2004) 252-259
62. Harsch I.A., Schahin S.P., Radespiel-Troger M., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169 2 (2004) 156-162
63. Babu A.R., Herdegen J., Fogelfeld L., et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165 4 (2005) 447-452
64. Reichmuth K.J., Austin D., Skatrud J.B., et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172 12 (2005) 1590-1595
65. Raff H., Bruder E.D., and Jankowski B.M. The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine 11 1 (1999) 37-39
66. Raff H., Bruder E.D., Jankowski B.M., et al. Effect of neonatal hypoxia on leptin, insulin, growth hormone and body composition in the rat. Horm Metab Res 33 3 (2001) 151-155
67. Cheng N., Cai W., Jiang M., et al. Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res 41 6 (1997) 852-856
68. Polotsky V.Y., Li J., Punjabi N.M., et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552 Pt 1 (2003) 253-264
69. Larsen J.J., Hansen J.M., Olsen N.V., et al. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 504 Pt 1 (1997) 241-249
70. Braun B., Rock P.B., Zamudio S., et al. Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 91 2 (2001) 623-631
71. Oltmanns K.M., Gehring H., Rudolf S., et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169 11 (2004) 1231-1237
72. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 9188 (1999) 1435-1439
73. Gottlieb D.J., Punjabi N.M., Newman A.B., et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 165 8 (2005) 863-867
74. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 4 (1995) 1897-1904
75. Leuenberger U., Jacob E., Sweer L., et al. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 79 2 (1995) 581-588
76. Smith M.L., Niedermaier O.N., Hardy S.M., et al. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Syst 56 3 (1996) 184-190
77. Narkiewicz K., and Somers V.K. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177 3 (2003) 385-390
78. Rowell L.B., Johnson D.G., Chase P.B., et al. Hypoxemia raises muscle sympathetic activity but not norepinephrine in resting humans. J Appl Physiol 66 4 (1989) 1736-1743
79. Somers V.K., Mark A.L., Zavala D.C., et al. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 67 5 (1989) 2101-2106
80. Peled N., Greenberg A., Pillar G., et al. Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome. Am J Hypertens 11 11 Pt 1 (1998) 1284-1289
81. Xie A., Skatrud J.B., Crabtree D.C., et al. Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol 89 4 (2000) 1333-1339
82. Xie A., Skatrud J.B., Puleo D.S., et al. Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 91 4 (2001) 1555-1562
83. Davies R.J., Belt P.J., Roberts S.J., et al. Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol 74 3 (1993) 1123-1130
84. Loredo J.S., Ziegler M.G., ncoli-Israel S., et al. Relationship of arousals from sleep to sympathetic nervous system activity and BP in obstructive sleep apnea. Chest 116 3 (1999) 655-659
85. Yoon I.Y., and Jeong D.U. Degree of arousal is most correlated with blood pressure reactivity during sleep in obstructive sleep apnea. J Korean Med Sci 16 6 (2001) 707-711
86. Lapinski M., Przybylowski T., Lewandowski J., et al. Diurnal blood pressure rhythm and urinary catecholamine excretion in obstructive sleep apnoea and essential hypertension. J Hypertens Suppl 11 5 (1993) S292-S293
87. Marrone O., Riccobono L., Salvaggio A., et al. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 103 3 (1993) 722-727
88. Dimsdale J.E., Coy T., Ziegler M.G., et al. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 18 5 (1995) 377-381
89. Fletcher E.C., Miller J., Schaaf J.W., et al. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10 1 (1987) 35-44
90. Jennum P., Wildschiodtz G., Christensen N.J., et al. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal Continuous Positive Airway Pressure (nCPAP) treatment. Am J Hypertens 2 11 Pt 1 (1989) 847-852
91. Hedner J., Darpo B., Ejnell H., et al. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 8 2 (1995) 222-229
92. Narkiewicz K., Kato M., Phillips B.G., et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 23 (1999) 2332-2335
93. Ziegler M.G., Mills P.J., Loredo J.S., et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 120 3 (2001) 887-893
94. Heitmann J., Ehlenz K., Penzel T., et al. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 23 2 (2004) 255-262
95. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43 5 (2000) 533-549
96. Deibert D.C., and DeFronzo R.A. Epinephrine-induced insulin resistance in man. J Clin Invest 65 3 (1980) 717-721
97. Raz I., Katz A., and Spencer M.K. Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle. Am J Physiol 260 3 Pt 1 (1991) E430-E435
98. Avogaro A., Toffolo G., Valerio A., et al. Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study. Diabetes 45 10 (1996) 1373-1378
99. Zeman R.J., Ludemann R., Easton T.G., et al. Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist. Am J Physiol 254 6 Pt 1 (1988) E726-E732
100. Lafontan M., and Berlan M. Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr Rev 16 6 (1995) 716-738
101. Roden M., Price T.B., Perseghin G., et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97 12 (1996) 2859-2865
102. Santomauro A.T., Boden G., Silva M.E., et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48 9 (1999) 1836-1841
103. Spath-Schwalbe E., Gofferje M., Kern W., et al. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 29 6 (1991) 575-584
104. Leproult R., Copinschi G., Buxton O., et al. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 20 10 (1997) 865-870
105. Moncloa F., Velasco I., and Beteta L. Plasma cortisol concentration and disappearance rate of 4-14C-cortisol in newcomers to high altitude. J Clin Endocrinol Metab 28 3 (1968) 379-382
106. Humpeler E., Skrabal F., and Bartsch G. Influence of exposure to moderate altitude on the plasma concentraton of cortisol, aldosterone, renin, testosterone, and gonadotropins. Eur J Appl Physiol Occup Physiol 45 2-3 (1980) 167-176
107. Maresh C.M., Noble B.J., Robertson K.L., et al. Aldosterone, cortisol, and electrolyte responses to hypobaric hypoxia in moderate-altitude natives. Aviat Space Environ Med 56 11 (1985) 1078-1084
108. Anand I.S., Chandrashekhar Y., Rao S.K., et al. Body fluid compartments, renal blood flow, and hormones at 6,000 m in normal subjects. J Appl Physiol 74 3 (1993) 1234-1239
109. Obminski Z., Golec L., Stupnicki R., et al. Effects of hypobaric-hypoxia on the salivary cortisol levels of aircraft pilots. Aviat Space Environ Med 68 3 (1997) 183-186
110. Barnholt K.E., Hoffman A.R., Rock P.B., et al. Endocrine responses to acute and chronic high altitude exposure (4300 m): modulating effects of caloric restriction. Am J Physiol Endocrinol Metab 290 6 (2006) E1078-E1088
111. Coste O., Beers P.V., Bogdan A., et al. Hypoxic alterations of cortisol circadian rhythm in man after simulation of a long duration flight. Steroids 70 12 (2005) 803-810
112. Entzian P., Linnemann K., Schlaak M., et al. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 153 3 (1996) 1080-1086
113. Grunstein R.R., Stewart D.A., Lloyd H., et al. Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 19 10 (1996) 774-782
114. Bratel T., Wennlund A., and Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 93 1 (1999) 1-7
115. Meston N., Davies R.J., Mullins R., et al. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 254 5 (2003) 447-454
116. Lanfranco F., Gianotti L., Pivetti S., et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) 60 1 (2004) 41-48
117. Parlapiano C., Borgia M.C., Minni A., et al. Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients. Endocr Res 31 4 (2005) 371-374
118. Pagano G., Cavallo-Perin P., Cassader M., et al. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 72 5 (1983) 1814-1820
119. Garvey W.T., Huecksteadt T.P., Monzon R., et al. Dexamethasone regulates the glucose transport system in primary cultured adipocytes: different mechanisms of insulin resistance after acute and chronic exposure. Endocrinology 124 5 (1989) 2063-2073
120. Wajngot A., Khan A., Giacca A., et al. Dexamethasone increases glucose cycling, but not glucose production, in healthy subjects. Am J Physiol 259 5 Pt 1 (1990) E626-E632
121. Coderre J.A., Button T.M., Micca P.L., et al. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 30 3 (1994) 643-652
122. Lambillotte C., Gilon P., and Henquin J.C. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 99 3 (1997) 414-423
123. Ohga E., Nagase T., Tomita T., et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87 1 (1999) 10-14
124. Chin K., Nakamura T., Shimizu K., et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109 7 (2000) 562-567
125. Dyugovskaya L., Lavie P., and Lavie L. Increased adhesion molecule expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165 7 (2002) 934-939
126. El-Solh A.A., Mador M.J., Sikka P., et al. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 121 5 (2002) 1541-1547
127. Ohga E., Tomita T., Wada H., et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94 1 (2003) 179-184
128. O'Brien L.M., Serpero L.D., Tauman R., et al. Plasma adhesion molecules in children with sleep-disordered breathing. Chest 129 4 (2006) 947-953
129. Ursavas A., Karadag M., Rodoplu E., et al. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration (2006)
130. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82 5 (1997) 1313-1316
131. Liu H., Liu J., Xiong S., et al. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ 20 3 (2000) 200-202
132. Alberti A., Sarchielli P., Gallinella E., et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 12 4 (2003) 305-311
133. Yokoe T., Minoguchi K., Matsuo H., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 8 (2003) 1129-1134
134. Minoguchi K., Tazaki T., Yokoe T., et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126 5 (2004) 1473-1479
135. Ryan S., Taylor C.T., and McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112 17 (2005) 2660-2667
136. Dyugovskaya L., Lavie P., and Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168 2 (2003) 242-249
137. Dyugovskaya L., Lavie P., and Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 1051 (2005) 340-350
138. Dyugovskaya L., Lavie P., Hirsh M., et al. Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25 5 (2005) 820-828
139. Klokker M., Kharazmi A., Galbo H., et al. Influence of in vivo hypobaric hypoxia on function of lymphocytes, neutrocytes, natural killer cells, and cytokines. J Appl Physiol 74 3 (1993) 1100-1106
140. Facco M., Zilli C., Siviero M., et al. Modulation of immune response by the acute and chronic exposure to high altitude. Med Sci Sports Exerc 37 5 (2005) 768-774
141. Zhang Y., Hu Y., and Wang F. Effects of a 28-Day "Living High-Training Low" on T-lymphocyte subsets in soccer players. Int J Sports Med 28 4 (2007) 354-358
142. Madden K.S., Sanders V.M., and Felten D.L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 35 (1995) 417-448
143. Elenkov I.J., Wilder R.L., Chrousos G.P., et al. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 4 (2000) 595-638
144. Meier-Ewert H.K., Ridker P.M., Rifai N., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43 4 (2004) 678-683
145. Uysal K.T., Wiesbrock S.M., Marino M.W., et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 6651 (1997) 610-614
146. Ventre J., Doebber T., Wu M., et al. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes 46 9 (1997) 1526-1531
147. Hotamisligil G.S. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes 107 2 (1999) 119-125
148. Youd J.M., Rattigan S., and Clark M.G. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes 49 11 (2000) 1904-1909
149. Hauner H. The mode of action of thiazolidinediones. Diabetes Metab Res Rev 18 Suppl 2 (2002) S10-S15
150. Hak A.E., Pols H.A., Stehouwer C.D., et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 86 9 (2001) 4398-4405
151. Pradhan A.D., Manson J.E., Rifai N., et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 3 (2001) 327-334
152. Steensberg A., Fischer C.P., Sacchetti M., et al. Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol 548 Pt 2 (2003) 631-638
153. Krogh-Madsen R., Plomgaard P., Moller K., et al. Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am J Physiol Endocrinol Metab 291 1 (2006) E108-E114
154. Pedersen B.K., Febbraio M.A., and Mooney R.A. Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 102 2 (2007) 814-816
155. Punjabi N.M., and Beamer B.A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30 1 (2007) 29-34
156. Ahima R.S., and Flier J.S. Leptin. Annu Rev Physiol 62 (2000) 413-437
157. Ceddia R.B., Koistinen H.A., Zierath J.R., et al. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 16 10 (2002) 1163-1176
158. Margetic S., Gazzola C., Pegg G.G., et al. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26 11 (2002) 1407-1433
159. Phillips B.G., Kato M., Narkiewicz K., et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279 1 (2000) H234-H237
160. Schafer H., Pauleit D., Sudhop T., et al. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122 3 (2002) 829-839
161. Ozturk L., Unal M., Tamer L., et al. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 129 5 (2003) 538-540
162. Patel S.R., Palmer L.J., Larkin E.K., et al. Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep 27 2 (2004) 235-239
163. Barcelo A., Barbe F., Llompart E., et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 171 2 (2005) 183-187
164. Shimura R., Tatsumi K., Nakamura A., et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest 127 2 (2005) 543-549
165. Tatsumi K., Kasahara Y., Kurosu K., et al. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 127 3 (2005) 716-721
166. Ulukavak C.T., Kokturk O., Bukan N., et al. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration 72 4 (2005) 395-401
167. McArdle N., Hillman D., Beilin L., et al. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175 2 (2007) 190-195
168. Sharma S.K., Kumpawat S., Goel A., et al. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8 1 (2007) 12-17
169. Harsch I.A., Konturek P.C., Koebnick C., et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22 2 (2003) 251-257
170. Sanner B.M., Kollhosser P., Buechner N., et al. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 23 4 (2004) 601-604
171. Maeda N., Shimomura I., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8 7 (2002) 731-737
172. Kubota N., Terauchi Y., Yamauchi T., et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277 29 (2002) 25863-25866
173. Spranger J., Kroke A., Mohlig M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 9353 (2003) 226-228
174. Harsch I.A., Wallaschofski H., Koebnick C., et al. Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 71 6 (2004) 580-586
175. Wolk R., Svatikova A., Nelson C.A., et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13 1 (2005) 186-190
176. Zhang X.L., Yin K.S., Mao H., et al. Serum adiponectin level in patients with obstructive sleep apnea hypopnea syndrome. Chin Med J (Engl) 117 11 (2004) 1603-1606
177. Masserini B., Morpurgo P.S., Donadio F., et al. Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 29 8 (2006) 700-705
178. Zhang X.L., Yin K.S., Wang H., et al. Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 73 1 (2006) 73-77
179. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 409 6818 (2001) 307-312
180. Silha J.V., Krsek M., Skrha J.V., et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149 4 (2003) 331-335
181. Fujinami A., Obayashi H., Ohta K., et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339 1-2 (2004) 57-63
182. Lee J.H., Chan J.L., Yiannakouris N., et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88 10 (2003) 4848-4856
183. Pfutzner A., Langenfeld M., Kunt T., et al. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 49 11-12 (2003) 571-576
184. Stejskal D., Adamovska S., Bartek J., et al. Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147 1 (2003) 63-69
185. Harsch I.A., Koebnick C., Wallaschofski H., et al. Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation?. Med Sci Monit 10 9 (2004) CR510-CR515
186. Guilleminault C., Briskin J.G., Greenfield M.S., et al. The impact of autonomic nervous system dysfunction on breathing during sleep. Sleep 4 3 (1981) 263-278
187. Rees P.J., Prior J.G., Cochrane G.M., et al. Sleep apnoea in diabetic patients with autonomic neuropathy. J R Soc Med 74 3 (1981) 192-195
188. Catterall J.R., Calverley P.M., Ewing D.J., et al. Breathing, sleep, and diabetic autonomic neuropathy. Diabetes 33 11 (1984) 1025-1027
189. Mondini S., and Guilleminault C. Abnormal breathing patterns during sleep in diabetes. Ann Neurol 17 4 (1985) 391-395
190. Neumann C., Martinez D., and Schmid H. Nocturnal oxygen desaturation in diabetic patients with severe autonomic neuropathy. Diabetes Res Clin Pract 28 2 (1995) 97-102
191. Ficker J.H., Dertinger S.H., Siegfried W., et al. Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J 11 1 (1998) 14-19
192. Bottini P., Dottorini M.L., Cristina C.M., et al. Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J 22 4 (2003) 654-660
193. Resnick H.E., Redline S., Shahar E., et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 26 3 (2003) 702-709
194. Hein M.S., Schlenker E.H., and Patel K.P. Altered control of ventilation in streptozotocin-induced diabetic rats. Proc Soc Exp Biol Med 207 2 (1994) 213-219
195. Polotsky V.Y., Wilson J.A., Haines A.S., et al. The impact of insulin-dependent diabetes on ventilatory control in the mouse. Am J Respir Crit Care Med 163 3 Pt 1 (2001) 624-632
196. Williams J.G., Morris A.I., Hayter R.C., et al. Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise. Thorax 39 7 (1984) 529-534
197. Montserrat J.M., Cochrane G.M., Wolf C., et al. Ventilatory control in diabetes mellitus. Eur J Respir Dis 67 2 (1985) 112-117
198. Sobotka P.A., Liss H.P., and Vinik A.I. Impaired hypoxic ventilatory drive in diabetic patients with autonomic neuropathy. J Clin Endocrinol Metab 62 4 (1986) 658-663
199. Nishimura M., Miyamoto K., Suzuki A., et al. Ventilatory and heart rate responses to hypoxia and hypercapnia in patients with diabetes mellitus. Thorax 44 4 (1989) 251-257
200. Weisbrod C.J., Eastwood P.R., O'Driscoll G., et al. Abnormal ventilatory responses to hypoxia in Type 2 diabetes. Diabet Med 22 5 (2005) 563-568
201. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 7 (1998) 539-553
202. Wilcox I., McNamara S.G., Collins F.L., et al. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53 Suppl 3 (1998) S25-S28
203. Coughlin S., Calverley P., and Wilding J. Sleep disordered breathing-a new component of syndrome x?. Obes Rev 2 4 (2001) 267-274
204. Brown L.K. A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. Chest 122 3 (2002) 774-778
205. Coughlin S.R., Mawdsley L., Mugarza J.A., et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25 9 (2004) 735-741
206. Vgontzas A.N., Bixler E.O., and Chrousos G.P. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9 3 (2005) 211-224
207. Boyko E.J., Leonetti D.L., Bergstrom R.W., et al. Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity: 5-year follow-up among initially nondiabetic Japanese-American men. Diabetes 45 8 (1996) 1010-1015
208. Hodge A.M., Dowse G.K., Alberti K.G., et al. Relationship of insulin resistance to weight gain in nondiabetic Asian Indian, Creole, and Chinese Mauritians. Mauritius Non-communicable Disease Study Group. Metabolism 45 5 (1996) 627-633
209. Odeleye O.E., de Courten M., Pettitt D.J., et al. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 46 8 (1997) 1341-1345
210. Folsom A.R., Vitelli L.L., Lewis C.E., et al. Is fasting insulin concentration inversely associated with rate of weight gain? Contrasting findings from the CARDIA and ARIC study cohorts. Int J Obes Relat Metab Disord 22 1 (1998) 48-54
211. Gould A.J., Williams D.E., Byrne C.D., et al. Prospective cohort study of the relationship of markers of insulin resistance and secretion with weight gain and changes in regional adiposity. Int J Obes Relat Metab Disord 23 12 (1999) 1256-1261
212. Srinivasan S.R., Myers L., and Berenson G.S. Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study. Metabolism 48 7 (1999) 928-934
213. Howard B.V., Adams-Campbell L., Allen C., et al. Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups. Int J Obes Relat Metab Disord 28 8 (2004) 1039-1047